Literature DB >> 21458227

The relationship among side effects associated with anti-epileptic medications in those with intellectual disability.

Megan Sipes1, Johnny L Matson, Brian Belva, Nicole Turygin, Alison M Kozlowski, Max Horovitz.   

Abstract

Seizures are fairly common in those with intellectual disabilities. In order to treat these seizures, antiepileptic drugs (AEDs) are often used and in many cases are effective. However, these medications often create a variety of associated side effects. In order to monitor these side effects, measures such as the SEIZES-B have been used. While many side effects have been found to occur with the use of AEDs, research has not explored if certain side effects are more likely to co-occur. For the current study, 281 people with intellectual disability were administered the SEIZES-B to monitor side effects associated with AEDs. Correlations between side effect subscales were then computed. Several subscales were found to be significantly correlated: hepatic disturbance with dermatological changes and cognitive disturbance; respiratory disturbance with dermatological changes, sedation, and electrolyte disturbance; and cognitive disturbance with sedation and dermatological disturbance. Possible implications of these findings are discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458227     DOI: 10.1016/j.ridd.2011.02.015

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  2 in total

1.  Recognition and treatment of mood dysregulation in adults with intellectual disability.

Authors:  Jason Noel
Journal:  Ment Health Clin       Date:  2018-11-01

2.  Economic burden of paediatric-onset disabilities among young and middle-aged adults in the USA: a cohort study of privately insured beneficiaries.

Authors:  Daniel Whitney; Neil Kamdar; Richard A Hirth; Edward A Hurvitz; Mark D Peterson
Journal:  BMJ Open       Date:  2019-09-03       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.